Comet Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-13. The offering totals $14.1M, of which $14.1M was reported sold. Industry: Other Technology.
| Name | Role | Location |
|---|---|---|
| LUCAS DE BREED | Director | CAMBRIDGE, MA |
| DAVID DE GRAAF, PH.D. | Director | CAMBRIDGE, MA |
| BERNARDUS MACHIELSE | Director | CAMBRIDGE, MA |
| HENRIJETTE RICHTER, PH.D. | Director | CAMBRIDGE, MA |
| PETER VAN VLASSELAER, PH.D. | Director | CAMBRIDGE, MA |
| DAVID DE GRAAF, PH.D. | Executive Officer | CAMBRIDGE, MA |
| ENEJ KUSCER, PH.D. | Executive Officer | CAMBRIDGE, MA |
| ART TAVERAS, PH.D. | Executive Officer | CAMBRIDGE, MA |